Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer

被引:16
|
作者
Aranza-Martinez, Alberto [1 ]
Sanchez-Perez, Julio [1 ]
Brito-Elias, Luis [1 ]
Lopez-Camarillo, Cesar [2 ]
Cantu de Leon, David [3 ]
Perez-Plasencia, Carlos [1 ,4 ]
Lopez-Urrutia, Eduardo [1 ]
机构
[1] UNAM, Lab Genom Func, Fac Estudios Super Iztacala, Tlalnepantla, Mexico
[2] Univ Autonoma Ciudad Mexico, Posgrad Ciencias Genom, Mexico City, DF, Mexico
[3] Inst Nacl Cancerol INCan, Direcc Invest, Mexico City, DF, Mexico
[4] Inst Nacl Cancerol INCan, Lab Genom, Mexico City, DF, Mexico
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
breast cancer; triple negative breast-cancer; radioresistance; non-coding RNAs; long non-coding RNAs; microRNAs; DNA-DAMAGE RESPONSE; ENHANCES RADIOSENSITIVITY; SIGNALING PATHWAYS; HOMOLOGOUS RECOMBINATION; IONIZING-RADIATION; INDUCED AUTOPHAGY; MASTER REGULATOR; DOWN-REGULATION; CELLS; REPAIR;
D O I
10.3389/fonc.2021.752270
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The resistance that Triple-Negative Breast Cancer (TNBC), the most aggressive breast cancer subtype, develops against radiotherapy is a complex phenomenon involving several regulators of cell metabolism and gene expression; understanding it is the only way to overcome it. We focused this review on the contribution of the two leading classes of regulatory non-coding RNAs, microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), against ionizing radiation-based therapies. We found that these regulatory RNAs are mainly associated with DNA damage response, cell death, and cell cycle regulation, although they regulate other processes like cell signaling and metabolism. Several regulatory RNAs regulate multiple pathways simultaneously, such as miR-139-5p, the miR-15 family, and the lncRNA HOTAIR. On the other hand, proteins such as CHK1 and WEE1 are targeted by several regulatory RNAs simultaneously. Interestingly, the study of miRNA/lncRNA/mRNA regulation axes increases, opening new avenues for understanding radioresistance. Many of the miRNAs and lncRNAs that we reviewed here can be used as molecular markers or targeted by upcoming therapeutic options, undoubtedly contributing to a better prognosis for TNBC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer
    Utpalendu Paul
    Satarupa Banerjee
    Molecular Biology Reports, 2022, 49 : 6899 - 6918
  • [22] Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer
    Rubén Rodríguez Bautista
    Alette Ortega Gómez
    Alfredo Hidalgo Miranda
    Alejandro Zentella Dehesa
    Cynthia Villarreal-Garza
    Federico Ávila-Moreno
    Oscar Arrieta
    Clinical Epigenetics, 2018, 10
  • [23] Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non-and triple-negative breast cancer
    Rodriguez Bautista, Ruben
    Ortega Gomez, Alette
    Hidalgo Miranda, Alfredo
    Zentella Dehesa, Alejandro
    Villarreal-Garza, Cynthia
    Avila-Moreno, Federico
    Arrieta, Oscar
    CLINICAL EPIGENETICS, 2018, 10
  • [24] A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer
    Wu, Jie
    Cai, Yan
    Zhao, Gaiping
    Li, Maolan
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (06)
  • [25] Long Non-Coding RNAs Associated with Recurrence of Breast Cancer
    Calle, Anna Sanchez
    Yamamoto, Yusuke
    Ochiya, Takahiro
    Takeshita, Fumitaka
    CANCER SCIENCE, 2018, 109 : 658 - 658
  • [26] Correction to: Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer
    Rubén Rodríguez Bautista
    Alette Ortega Gómez
    Alfredo Hidalgo Miranda
    Alejandro Zentella Dehesa
    Cynthia Villarreal-Garza
    Federico Ávila-Moreno
    Oscar Arrieta
    Clinical Epigenetics, 2018, 10
  • [27] The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs
    Chen, Ziyi
    Zhao, Yi
    FRONTIERS IN PHARMACOLOGY, 2025, 15
  • [28] Wnt signaling in triple-negative breast cancers: Its roles in molecular subtyping and cancer cell stemness and its crosstalk with non-coding RNAs
    Yang, Xinzhi
    Cao, Deliang
    Ma, Wenqian
    Gao, Shuqin
    Wen, Gebo
    Zhong, Jing
    LIFE SCIENCES, 2022, 300
  • [29] Extracellular vesicle-derived non-coding RNAs to predict outcome in patients with triple-negative breast cancer (TNBC) with residual disease (RD).
    Stecklein, Shane R.
    Koestler, Devin
    Yellapu, Nanda K.
    Yoder, Rachel
    Kimler, Bruce F.
    Staley, JoshuaM.
    Schmitt, Zachary
    Khan, Qamar J.
    O'Dea, Anne
    Nye, Lauren Elizabeth
    Elia, Manana
    Heldstab, Jaimie
    Home, Trisha
    Hyter, Stephen
    Isakova, Kamilla
    Pathak, Harsh B.
    Godwin, Andrew K.
    Sharma, Priyanka
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Breast Cancer and the Other Non-Coding RNAs
    Dvorska, Dana
    Brany, Dusan
    Nachajova, Marcela
    Halasova, Erika
    Dankova, Zuzana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06)